PER 0.00% 8.4¢ percheron therapeutics limited

For General Information, page-241

  1. 3,215 Posts.
    lightbulb Created with Sketch. 258
    Couple of questions:
    - For well over a year Diamond has been continuously repeating in all his wisdom that ATL1102 can/will be utilized
    for other indications (pls note plural therefore I understand it means several)
    - Ms. C. Gittleson the chair came out with a very strong statement: ANP will own the DMD space.

    Considering the position in the company (public company better mention) of the two above personalities their comments/statements have a certain weight of importance within the shareholders community, the market and why not also within the scientific community/space/world.
    Well with much disbelief (or maybe not from the market side) such “strong trustful” leadership resulted in a continuous share price drop and a daily share traded amount at ridiculous level. In other words no interest or whatsoever.
    I don’t want to analyze the professional credibility and/or of at least one of the two individual therefore is there someone, anybody old or new share holder that can come up with a logical explanation of why all this failure after above mentioned management’s comments?
    Please spare me/us in blaming Putin.
    Last edited by imperatore: 05/05/22
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
0.000(0.00%)
Mkt cap ! $75.73M
Open High Low Value Volume
8.4¢ 8.5¢ 8.4¢ $31.98K 379.3K

Buyers (Bids)

No. Vol. Price($)
2 262571 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 119843 1
View Market Depth
Last trade - 14.51pm 19/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.